Evidence map›Paper›PMID 25595323›Full record

ReviewPharmacology & therapeutics2015

Sex steroid signaling: implications for lung diseases.

Venkatachalem Sathish, Yvette N Martin, Y S Prakash

Open access · greenAbstract readReview
In one paragraph

Review in Pharmacology & therapeutics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 1 synthesis or guideline pooled it, 172 citations in OpenAlex.

  1. Sex Differences in Exercise-Induced Bronchoconstriction in Athletes: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2020
    Pooled it
  2. Review
  3. Article
  4. Sex, hormones, and lung health.Physiological reviews · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Lung Function as a Biomarker for Glaucoma: The UK Biobank Study.Investigative ophthalmology & visual science · 2025
    Article
  13. Aging, brain-derived neurotrophic factor, and allergen-induced pulmonary responses in mice.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Venkatachalem SathishDepartment of Physiology and Biomedical Engineering, College of Medicine, Mayo Clinic, Rochester, MN, USA; Department of Anesthesiology, College of Medicine, Mayo Clinic, Rochester, MN, USA.
Yvette N MartinDepartment of Physiology and Biomedical Engineering, College of Medicine, Mayo Clinic, Rochester, MN, USA; Department of Anesthesiology, College of Medicine, Mayo Clinic, Rochester, MN, USA.
Y S PrakashDepartment of Physiology and Biomedical Engineering, College of Medicine, Mayo Clinic, Rochester, MN, USA; Department of Anesthesiology, College of Medicine, Mayo Clinic, Rochester, MN, USA. Electronic address: prakash.ys@mayo.edu.
Mayo Clinic · US

Funding

NEURAL REGULATION OF AIRWAYS DURING POSTNATAL MATURATIONR01HL056470 · NHLBI · MAYO CLINIC ROCHESTER · PI PRAKASH, Y. S. · 1996 to 2025
$10.5M
Neurotrophins in the LungR01HL088029 · NHLBI · MAYO CLINIC ROCHESTER · PI PRAKASH, Y. S. · 2009 to 2022
$5.9M
NHLBI NIH HHS R01 HL056470NHLBI NIH HHS R01 HL088029
6 · The paper itself

Abstract

There is increasing recognition that sex hormones (estrogen, progesterone, and testosterone) have biological and pathophysiological actions in peripheral, non-reproductive organs, including the lung. Clinically, sex differences in the incidence, morbidity and mortality of lung diseases such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, lung cancer and pulmonary hypertension have been noted, although intrinsic sex differences vs. the roles of sex steroids are still not well-understood. Accordingly, it becomes important to ask the following questions: 1) Which sex steroids are involved? 2) How do they affect different components of the lung under normal circumstances? 3) How does sex steroid signaling change in or contribute to lung disease, and in this regard, are sex steroids detrimental or beneficial? As our understanding of sex steroid signaling in the lung improves, it is important to consider whether such information can be used to develop new therapeutic strategies to target lung diseases, perhaps in both sexes or in a sex-specific manner. In this review, we focus on the basics of sex steroid signaling, and the current state of knowledge regarding how they influence structure and function of specific lung components across the life span and in the context of some important lung diseases. We then summarize the potential for sex steroids as useful biomarkers and therapeutic targets in these lung diseases as a basis for future translational research in the area of gender and individualized medicine.

Indexed as

AnimalsCholesterolEstrogensFemaleHumansLungLung DiseasesMaleMuscle, SmoothProgesteroneRespiratory MucosaRespiratory SystemSex FactorsSignal TransductionTestosteroneCholesterolEstrogensProgesteroneTestosteroneAirwayAlveoliAsthmaCOPDEstrogenHormoneProgesteronePulmonary fibrosisTestosterone

Identifiers

PMID25595323
PMCPMC4523383
OpenAlexW2077258706

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.